CNS vs NP
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
CNS exhibits a stable financial foundation with a Piotroski F-Score of 5/9 and very low debt (D/E 0.22), but it is fundamentally overvalued. The current price of $67.71 trades at a significant premium to both the Graham Number ($27.35) and the growth-based Intrinsic Value ($50.59). This valuation gap is compounded by a bearish technical trend (0/100), insider selling, and a dangerously high dividend payout ratio of 83.77%. Recent earnings performance is lackluster, with only one beat in the last four quarters.
The deterministic health profile is critical, highlighted by a Piotroski F-Score of 1/9, indicating severe financial weakness. While revenue growth remains strong at 28.8%, the company exhibits a catastrophic Price/Book ratio of -16.29, suggesting negative shareholders' equity. Liquidity is precarious with a Quick Ratio of 0.21, and a sharp Q/Q earnings decline of 26.1% contradicts the bullish analyst consensus. The stock is fundamentally overvalued on a Price/Sales basis (20.69x) and lacks any deterministic value floor.
Compare Another Pair
Related Comparisons
CNS vs NP: Head-to-Head Comparison
This page compares Cohen & Steers, Inc. (CNS) and Neptune Insurance Holdings Inc. (NP) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.